What You Should Know:
– Sunrise, an innovator in sleep disorder diagnostics, is bringing its technology and services to the United States through the acquisition of Dreem Health, a California-based sleep clinic.
– The strategic move aims to democratize and accelerate access to sleep care for millions of Americans. Financial details of the acquisition were not disclosed.
Revolutionizing Sleep Care with Technology
Sunrise has developed proprietary technology for diagnosing sleep disorders, offering a more convenient and accessible alternative to traditional sleep studies. By combining this technology with Dreem Health’s established network of partnerships with major insurers and Medicare, Sunrise aims to make sleep care more affordable and readily available to those who need it.
Expanding Access to Sleep Diagnostics
Through the acquisition of Dreem Health, Sunrise will be able to:
- Offer telehealth services: Provide remote consultations and diagnoses for sleep disorders.
- Expand insurance coverage: Leverage Dreem Health’s existing partnerships to make its diagnostic services more accessible.
- Increase its reach: Expand its services to patients across the United States.
Scaling Operations and Growth
Sunrise has set ambitious goals for the US market, aiming to:
- Become the largest sleep clinic in the country.
- Significantly increase revenue.
- Expand access to sleep care nationwide by 2025.
To support its expansion in the US, Sunrise has appointed Laura Warnier as Chief Growth Officer. Warnier brings extensive experience in scaling startups, having previously played a key role in the rapid growth of EdTech company GoStudent. Her expertise will be crucial in driving Sunrise’s expansion and achieving its ambitious goals for market leadership in the US sleep care industry.
“As we build out our U.S. presence, Sunrise is set to innovate the global sleep health market,” said Laurent Martinot, Founder and CEO of Sunrise. “Since launching Sunrise in 2015, we’ve seen impressive growth driven by innovations in home sleep testing. However, the pace of change hasn’t been fast enough, and there’s still a major need for sleep health education. At Sunrise, we are committed to ensuring sleep disorders are properly recognized, diagnosed, and treated. With strategic moves like the acquisition of Dreem Health and the appointment of Laura Warnier as Chief Growth Officer, we’re strengthening our capabilities and establishing Sunrise as the global leader in sleep health.”
